EU Bolar exemption is not so simple
The EU directive to introduce a US-style Bolar provision promised to harmonise the law on clinical trials. But, says Marina Barnden, inconsistent application has led to uncertainty
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: